Canopy Growth Corporation Share Price

Equities

WEED

CA1380357048

Pharmaceuticals

Delayed Toronto S.E. 01:30:00 17/07/2024 am IST 5-day change 1st Jan Change
10.06 CAD +3.29% Intraday chart for Canopy Growth Corporation +18.77% +48.82%

Financials

Sales 2025 * 302M 221M 18.46B Sales 2026 * 325M 238M 19.86B Capitalization 767M 560M 46.81B
Net income 2025 * -135M -98.67M -8.24B Net income 2026 * -115M -84.05M -7.02B EV / Sales 2025 * 4.6 x
Net Debt 2025 * 624M 456M 38.11B Net Debt 2026 * 807M 590M 49.28B EV / Sales 2026 * 4.84 x
P/E ratio 2025 *
-6.05 x
P/E ratio 2026 *
-8.09 x
Employees 1,029
Yield 2025 *
-
Yield 2026 *
-
Free-Float 99.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.29%
1 week+18.77%
Current month+13.80%
1 month+0.70%
3 months+8.87%
6 months+55.49%
Current year+48.82%
More quotes
1 week
8.48
Extreme 8.48
10.24
1 month
8.28
Extreme 8.28
10.24
Current year
3.74
Extreme 3.74
20.50
1 year
3.74
Extreme 3.74
26.00
3 years
3.74
Extreme 3.74
257.50
5 years
3.74
Extreme 3.74
716.00
10 years
3.74
Extreme 3.74
766.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 01/18/01
Director of Finance/CFO 52 02/19/02
Investor Relations Contact - 01/16/01
Members of the board TitleAgeSince
Chief Executive Officer 60 01/18/01
Chairman 69 31/20/31
Director/Board Member 67 31/20/31
More insiders
Date Price Change Volume
16/24/16 10.06 +3.29% 2,229,913
15/24/15 9.74 +9.81% 1,913,985
12/24/12 8.87 +0.45% 819,738
11/24/11 8.83 +2.56% 1,019,757
10/24/10 8.61 +1.65% 911,807

Delayed Quote Toronto S.E., July 17, 2024 at 01:30 am IST

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
10.06 CAD
Average target price
9.236 CAD
Spread / Average Target
-8.19%
Consensus